Wen-Qian Kang

Wen-Qian Kang

Auto-generated profile, based on publicly available information

Wen-Qian Kang

Shaanxi University of Chinese Medicine, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
WKWen-Qian Kang
Wen-Qian Kang
PWPei-Feng Wei
Pei-Feng Wei
LOLi Ou
Li Ou
MLMin Li
Min Li
CLChun-Yu Liu
Chun-Yu Liu
To observe the mechanism of prepared Radix Rehmanniainon combined with Radix Astragali in treating osteoporosis. Osteoporosis rat model was established by bilateral ovariectomy combined with low-calcium diet feeding. Bone mineral density was measured by bone densitometer. Bone metabolism markers in serum were detected by enzyme linked immunosorbent assay (ELISA), bone tissue structure was observed by hematoxylin-eosin staining, and the effect of prepared Radix Rehmanniainon combined with Radix Astragali on PI3K-AKT signaling pathway was investigated by immunohistochemistry and reverse transcription polymerase chain reaction. Compared with the model group, the bone tissue structure and imbalance of bone metabolism were improved, and the bone mineral density was significantly increased in the prepared Radix Rehmanniainon combined with Radix Astragali groups. After intervention with prepared Radix Rehmanniainon combined with Radix Astragali, the positive expression of PIK3CA and Akt1 in rat bone tissue was enhanced, and the expression levels of Akt1 mRNA were significantly increased. Prepared Radix Rehmanniainon combined with Radix Astragali may treat osteoporosis by activating PI3K/AKT pathway.